These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23422504)

  • 1. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
    Lee JY; Myung SK; Song YS
    Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.
    Huang M; Chen Q; Xiao J; Liu C; Zhao X
    Int J Cancer; 2013 Jan; 132(2):363-73. PubMed ID: 22729746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.
    Sun S; Cai J; Yang Q; Zhu Y; Zhao S; Wang Z
    PLoS One; 2016; 11(11):e0166058. PubMed ID: 27812204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase serves as a biomarker for worse survival profiles in ovarian cancer patients: an updated meta-analysis.
    Xia Y; Wei X; Gong H; Ni Y
    BMC Womens Health; 2018 Dec; 18(1):199. PubMed ID: 30522488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 expression in ovarian cancer: an updated meta-analysis.
    Sun H; Zhang X; Sun D; Jia X; Xu L; Qiao Y; Jin Y
    Oncotarget; 2017 Oct; 8(50):88152-88162. PubMed ID: 29152148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.
    Beeghly-Fadiel A; Wilson AJ; Keene S; El Ramahi M; Xu S; Marnett LJ; Fadare O; Crispens MA; Khabele D
    J Ovarian Res; 2018 Feb; 11(1):17. PubMed ID: 29482584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
    Jia H; Zhang Q; Liu F; Zhou D
    Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
    Li LN; Zhou X; Gu Y; Yan J
    Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang HS; Yoon C; Myung SK; Park SM
    Int J Gynecol Cancer; 2011 Dec; 21(9):1525-32. PubMed ID: 22080892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
    Klar M; Hasenburg A; Hasanov M; Hilpert F; Meier W; Pfisterer J; Pujade-Lauraine E; Herrstedt J; Reuss A; du Bois A
    Eur J Cancer; 2016 Oct; 66():114-24. PubMed ID: 27561452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of concomitant p53 and PTEN on outcome in early stage (FIGO I-II) epithelial ovarian cancer.
    Skírnisdóttir I; Seidal T
    Int J Gynecol Cancer; 2011 Aug; 21(6):1024-31. PubMed ID: 21792012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
    Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
    Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
    Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
    Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of cyclooxygenase-2 expression in head and neck cancer: A meta-analysis.
    Yang B; Jia L; Guo Q; Ren H; Hu Y; Xie T
    Oncotarget; 2016 Jul; 7(30):47265-47277. PubMed ID: 27323811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of systematic retroperitoneal lymphadenectomy in patients with epithelial ovarian cancer: a Meta-analysis].
    Gu HF; Zhou Y; Li YX; Ou YL; Liu JH
    Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3020-3025. PubMed ID: 27760666
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
    Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
    Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
    Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.